JenaValve Trilogy Heart Valve System

DEVICE2 trials

Sponsors

JenaValve Technology, Inc.

Conditions

Aortic InsufficiencyAortic RegurgitationAortic Valve DiseaseAortic Valve InsufficiencyLeft Ventricular Dysfunction

Unknown Phase

The JenaValve ALIGN-AR Pivotal Trial

Active, not recruitingNCT04415047

JenaValve Technology, Inc.Aortic Insufficiency, Aortic Regurgitation, Aortic Valve Disease +1

Start: 2020-05-22End: 2028-08-31Updated: 2022-09-13

The JenaValve ALIGN-AR LVAD Registry

Active, not recruitingNCT06594705

JenaValve Technology, Inc.Aortic Insufficiency, Aortic Regurgitation, Aortic Valve Disease +2

Start: 2024-12-09End: 2027-08-01Updated: 2026-07-22

Related Papers

Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption study.

2025-11-162 citations

Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study.

2024-03-2679 citations

Treatment of Symptomatic Aortic Regurgitation - Disparities, Disparities, Disparities

Structural Heart2021-11-01